BIOX processing plant.
(Source: Endeavour Mining plc)
  • Endeavour Mining (TSX:EDV) achieved commercial production at its Sabodala-Massawa BIOX Expansion in Senegal and at its Lafigué mine in Côte d’Ivoire
  • The BIOX Expansion is operating with 94 per cent plant availability at 80 per cent of nameplate capacity, with the company pointing to average recoveries of above 72 per cent during July and August
  • The Lafigué mine achieved commercial production only one month after the first gold pour; operating with 87 per cent plant availability at 72 per cent of nameplate capacity, with average recoveries of above 95 per cent during August
  • Endeavour Mining last traded at C$30.63 per share

Endeavour Mining (TSX:EDV) achieved commercial production at its Sabodala-Massawa BIOX Expansion in Senegal and at its Lafigué mine in Côte d’Ivoire.

In its move to fully de-risk construction and ramp-up activities, commercial production was reached on budget and on schedule at both projects on Aug. 1.

“Both projects will drive stronger operating performance in the second half of the year, underpinning our group production guidance, while adding low-cost production, extending mine life visibility, and increasing the geographic diversification of the portfolio,” the company’s CEO, Ian Cockerill, said in a news release. “The completion of this phase of growth is a significant milestone for Endeavour.”

The BIOX Expansion is operating with 94 per cent plant availability at 80 per cent of nameplate capacity, with the company pointing to average recoveries of above 72 per cent during July and August.

Situated about 630 kilometres east-southeast of Dakar, Senegal’s capital, the Sabodala-Massawa mine features multiple open-pit operations within the highly promising Birimian Greenstone Belt.

Meanwhile, the Lafigué mine achieved commercial production only one month after the first gold pour; operating with 87 per cent plant availability at 72 per cent of nameplate capacity, with average recoveries of above 95 per cent during August.

The Lafigué mine is towards the northern end of the Birimian aged Oumé-Fetekro greenstone belt, in north-central Côte d’Ivoire, roughly 500 km from Abidjan by road.

The company insists it remains on track to achieve its full-year production guidance with all-in sustaining costs near the top end of the guided range.

Endeavour Mining is one of the world’s senior gold producers and the largest in West Africa, with operating assets across Senegal, Cote d’Ivoire and Burkina Faso and a strong portfolio of advanced development projects and exploration assets in the highly prospective Birimian Greenstone Belt across West Africa.

Endeavour Mining (TSX:EDV) last traded at C$30.63 per share, and its stock is up 7.40 per cent this week, 1.01 per cent higher since the year began.

Join the discussion: Find out what everybody’s saying about this stock on the Endeavour Mining plc. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: BIOX processing plant via Endeavour Mining plc)


More From The Market Online
AI generated image of investors

How to trade on the stock market: A beginner’s guide

Interactive Brokers Group (NDAQ:IBKR) is an online brokerage with a global reach, serving clients in more than 200 countries and territories.
Foran’s exploration team conducting field-based activities such as structural geology mapping during the 2024 field season in Saskatchewan.

Foran plans to explore depths of Saskatchewan’s mineral potential

Foran Mining Corp. (TSX:FOM) is making the most out of its properties across Saskatchewan, specifically the Tesla Zone discovery.
The Alvalade copper and zinc joint venture in Portugal

Avrupa Minerals stock reaches new high after stellar results

Avrupa Minerals stock (TSXV:AVU) surpasses its yearly high after releasing new results from drilling at its Sesmarias project in Portugal.
healthcare worker holding pink ribbon representing breast cancer awareness

Oncolytics Biotech reports positive results from breast cancer study

Oncolytics Biotech (TSX:ONC) revealed results from its Phase 2 study in patients with advanced or metastatic breast cancer.